Louisiana Welder's Anthrax Case Treated with Monoclonal Antibody

A rare case of welder's anthrax in Louisiana was successfully treated with the monoclonal antibody obiltoxaximab, marking the first clinical use of this treatment for the condition, which is often fatal. The patient showed rapid improvement after receiving the drug alongside standard antimicrobial therapy, highlighting the potential of antitoxin treatments for this rare disease.